VA Northeast Program Evaluation Center, West Haven and Yale University, New Haven, Connecticut
University of North Carolina, Chapel Hill, North Carolina
Duke University, Durham, North Carolina
University of North Carolina, Chapel Hill, North Carolina
National Institutes of Mental Health, Bethesda, Maryland
University of California at San Francisco, San Francisco, California
University of North Carolina, Chapel Hill, North Carolina, USA
Correspondence: Dr Robert Rosenheck, Northeast Program Evaluation Center (182), VA Connecticut Health Care System, 950 Campbell Avenue, West Haven, CT 06516, USA. Tel: +1 203 937 3850; fax: +1 203 937 3433; e-mail: Robert.Rosenheck{at}Yale.edu
Background Measures have not taken account of the relative importance patients place on various outcomes.
Aims To construct and evaluate a multidimensional, preference-weighted mental health index.
Method Each of over 1200 patients identified the relative importance of improvement in six domains: social life, energy, work, symptoms, confusion and side-effects. A mental health index was created in which measures of well-being in these six domains were weighted for their personal importance.
Results The strongest preference was placed on reducing confusion and the least on reducing side-effects. There was no significant difference between the unweighted and preference-weighted mental health status measures and they had similar correlations with global health status measures. Patients with greater preference for functional activities such as work had less preference for medical model goals such as reducing symptoms and had less symptoms.
Conclusions A preference-weighted mental health index demonstrated no advantage over an unweighted index.
Related articles in BJP:
This article has been cited by other articles:
![]() |
D. D. Miller, S. N. Caroff, S. M. Davis, R. A. Rosenheck, J. P. McEvoy, B. L. Saltz, S. Riggio, M. H. Chakos, M. S. Swartz, R. S. E. Keefe, et al. Extrapyramidal side-effects of antipsychotics in a randomised trial The British Journal of Psychiatry, October 1, 2008; 193(4): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. PRIEBE, R. McCABE, J. BULLENKAMP, L. HANSSON, C. LAUBER, R. MARTINEZ-LEAL, W. ROSSLER, H. SALIZE, B. SVENSSON, F. TORRES-GONZALES, et al. Structured patient clinician communication and 1-year outcome in community mental healthcare: Cluster randomised controlled trial The British Journal of Psychiatry, November 1, 2007; 191(5): 420 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. McCabe, M. Saidi, and S. Priebe Patient-reported outcomes in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s21 - s28. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Salkever, M. C. Karakus, E. P. Slade, C. M. Harding, R. L. Hough, R. A. Rosenheck, M. S. Swartz, C. Barrio, and A. M. Yamada Measures and Predictors of Community-Based Employment and Earnings of Persons With Schizophrenia in a Multisite Study Psychiatr Serv, March 1, 2007; 58(3): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Swartz, D. O. Perkins, T. S. Stroup, S. M. Davis, G. Capuano, R. A. Rosenheck, F. Reimherr, M. F. McGee, R. S.E. Keefe, J. P. McEvoy, et al. Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study Am J Psychiatry, March 1, 2007; 164(3): 428 - 436. [Abstract] [Full Text] [PDF] |
||||